Styrketræning af musklerne hos patienter med nedre ekstremitetsamputation
Effekter af muskelstyrketræning hos patienter med amputation af underkroppen
This study is a clinical trial that evaluates the best treatment option using a strength training protocol and an endurance training protocol in patients with lower limb amputations who use prostheses. The protocol consists of 6 weeks of strength training and 6 weeks of endurance training, with a 1-month washout period between the two.
Studieoversigt
Status
Status
Betingelser
Betingelser
Intervention / Behandling
Intervention / Behandling
Detaljeret beskrivelse
The assessments in this study focus primarily on strength, using a dynamometer and the 5 RM, functionality, using the AMP scale, mobility, using the TugTest, quality of life, using the WHOQOL-BREF, and perception of change, using the GROC.
Undersøgelsestype
Undersøgelsestype
Tilmelding (Anslået)
Tilmelding
Fase
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiekontakt
Studiekontakt
- Navn: Gabriela B Dell´Elce
- Telefonnummer: +54 3462344478
- E-mail: gdellelce@ugr.edu.ar
Studiesteder
-
-
Santa Fe Province
-
Rosario, Santa Fe Province, Argentina, 2000
- Rekruttering
- Universidad del Gran Rosario
-
Kontakt:
- Gabriela B Dell´Elce, Pt
- Telefonnummer: 3462 344478
- E-mail: gdellelce@ugr.edu.ar
-
-
Deltagelseskriterier
Berettigelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Patients with unilateral lower limb amputation
- Transtibial and/or transfemoral amputation
- Prosthetized
- Aged 18 to 75 years
- Who sign the informed consent form
Exclusion Criteria:
- That they are unable to complete the initial assessment
- That they undergo further secondary training
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Crossover opgave
- Maskning: Enkelt
Antal våben
Våben og indgreb
Deltagergruppe / ArmDeltagergruppe / Arm |
Intervention / BehandlingIntervention / Behandling |
|---|---|
|
Eksperimentel: Muscle strength training
Strength training lasts six weeks, during which submaximal strength percentages ranging from 75% to 90% are worked on. It is performed three times a week and follows a protocol consisting of progressive exercises for the large functional muscle groups relevant to the population being trained. |
Strength training lasts six weeks, during which submaximal strength percentages ranging from 75% to 90% are worked on. It is performed three times a week and follows a protocol consisting of progressive exercises for the large functional muscle groups relevant to the population being trained. |
|
Aktiv komparator: Endurance training
Resistance training will be carried out for 6 weeks, 3 times a week, with exercises prescribed by a protocol with training characteristics defined by bibliography found in the ACSM. |
Resistance training will be carried out for 6 weeks, 3 times a week, with exercises prescribed by a protocol with training characteristics defined by bibliography found in the ACSM. |
Hvad måler undersøgelsen?
Primære resultatmål
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Changes in Funcionality
Tidsramme: day 1, day 18 (last day of week 6), day 1 (after the wash out) and day 24.
|
It is assessed using the TUG test, which requires patients to get up from a chair, walk 3 meters, turn around, walk back to the chair, and sit down again. Patients will receive the following instructions: "Get up on the word 'go,' walk to the tape, turn around, walk back to the chair, and sit down." |
day 1, day 18 (last day of week 6), day 1 (after the wash out) and day 24.
|
|
Changes in quality of life
Tidsramme: day 1, day 18 (last day of week 6), day 1 (after the wash out) and day 24.
|
It is assessed using a self-administered questionnaire called WHOQOL-BREF, which provides a profile of the person's perceived quality of life. |
day 1, day 18 (last day of week 6), day 1 (after the wash out) and day 24.
|
Sekundære resultatmål
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Changes in Maximum isometric muscle strength
Tidsramme: day 1, day 18 (last day of week 6), day 1 (after the wash out) and day 24.
|
It is evaluated using a dynamometer, in which three measurements are taken for each designated movement and the average of the maximum force and peak force is calculated. |
day 1, day 18 (last day of week 6), day 1 (after the wash out) and day 24.
|
|
Changes on Movility
Tidsramme: day 1, day 18 (last day of week 6), day 1 (after the wash out) and day 24.
|
It is assessed using the AMP functional rating scale (amputee mobility predictor). |
day 1, day 18 (last day of week 6), day 1 (after the wash out) and day 24.
|
|
Change in Global percepcion of change
Tidsramme: assessments were performed at the end each protocol. day 18 and day 24
|
It is an assessment carried out using the Groc scale, which evaluates changes in perception. |
assessments were performed at the end each protocol. day 18 and day 24
|
Samarbejdspartnere og efterforskere
Sponsor
Sponsor
Efterforskere
Efterforskere
- Studieleder: Mauro S Barone, Ugr
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Studiestart
Primær færdiggørelse (Anslået)
Primær færdiggørelse
Studieafslutning (Anslået)
Studieafslutning
Datoer for studieregistrering
Først indsendt
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Først opslået
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering sendt
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Andre undersøgelses-id-numre
Andre undersøgelses-id-numre
- 619/2024
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
IPD-planbeskrivelse
If necessary or required, informed consent and data analysis will be shared.
IPD-deling Understøttende informationstype
- SAP
- ICF
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .